Saturday, June 6, 2026

Samsung SDI Set for Growth: Will U.S. Restrictions on Chinese ESS Boost Stock by 52%?

Daol Investment & Securities raises Samsung SDI's target price, citing benefits from U.S. restrictions on Chinese energy storage systems.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Diplomatic Drama: Ex-South Korean First Lady Accused of Fabricating Official Invitations

The prosecution has begun investigating People's Power...

Dae Hyeon Moon

Author's Latest

Wontec’s Bold Move: 6 Billion KRW Buyback to Boost Shareholder Value in 2026

Wontech plans to repurchase shares worth 6 billion KRW to boost shareholder value and confidence, aiming for strong growth by 2025.

HLB Life Science R&D: Leading the Charge in CBD Pharmaceutical Development in 2026

HLB Life Science R&D partners for a national project to develop medical cannabis-based pharmaceuticals, focusing on CBD production.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

Discover the Benefits of Daewon Pharmaceutical’s New Liquid Health Supplements: A Guide to Sleep, Stress, and Immunity

Daewon Pharmaceutical launches a pop-up store at Olive Young, showcasing three innovative liquid health supplements for diverse needs.

How Penetrium’s Innovative Approach Could Change Cancer Treatment Forever

Penetrium Bioscience will unveil a new therapeutic mechanism for treating cancer and other diseases on April 16 in Seoul.

First Patient Registered in Vietnam: A Milestone for Dengue Treatment Trials by Hyundai BioScience

Hyundai Bio Science has registered its first patient for a dengue treatment trial in Vietnam, marking a significant milestone.

Lunit’s AI Innovations: How a Meeting with France’s SGPI Could Transform Healthcare

Lunit discusses collaboration with France's SGPI to enhance medical AI technology in public healthcare, aligning with a strategic partnership.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

K-Beauty Revolution: Jenecell’s Stem Cell Skincare Launch in 2026

Jenecell launches a K-beauty skincare line, partnering with Helios for stem cell culture medium to enhance product performance and market reach.

HLB Genex and KAIST Join Forces: Revolutionary Brain Health Solutions in 2026

HLB Genex partners with KAIST to develop innovative brain health solutions, merging research with commercialization to address social challenges.

FDA Grants Orphan Drug Status to Tovecimig: What This Means for Cholangiocarcinoma Treatment

ABL Bio's Tovecimig receives Orphan Drug Designation from the FDA, enhancing its approval prospects for cholangiocarcinoma treatment.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.